![Marc Lemaire](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Lemaire held positions as Director of Healthcare Program at Air Liquide SA, Director of Supervisory Board at Sangamo Therapeutics France SAS, and Principal at Hoechst AG.
| Unternehmen | Position | Ende |
|---|---|---|
| AIR LIQUIDE | Corporate Officer/Principal | - |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Corporate Officer/Principal | - |
| TXCELL | Direktor/Vorstandsmitglied | 17.02.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Hoechst AG
Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
Air Liquide SA
 Air Liquide SA Chemicals: SpecialtyProcess Industries Supplies gases, technologies and services for the industry & health businesses | Process Industries |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
